Category Archives: Immortalization

Reprogramming Lung Cancer to Self-Destruct Using TRAIL and CDK9 Inhibitor

CANCER RESEARCH UK scientists have found a drug combination that can trigger the self-destruct process in lung cancer cells – paving the way for new treatments, according to research that will be presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool next week. This process is known as apoptosis. Continue reading

HPV DNA Test and Experimental DNA Vaccine

The National Cancer Institute states that “virtually all” cervical cancers are caused by HPV infection.  The association is so strong that the FDA recently approved a DNA test for HPV that many believe could supplant PAP smear.  This is great news for patients who do not have cervical cancer, yet.  But what if you do?… Continue reading

FDA Clinical Hold lifted on telomerase inhibitor

In clinical trials, “clinical holds” are imposed by the FDA when toxicities emerge that are unexpected, either new toxicities that have not been seen before, (or were not anticipated) or increased severity of known or anticipated side effects.  The hold allows the FDA to assess the data, demand more data from the sponsoring companies, and make appropriate changes in the study protocol… Continue reading